SCHEMBL665290

SCHEMBL665290

CCCCCCCCCCOC(=S)S

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.59
CA1 P00915 3/20 0.59
CA2 P00918 3/20 0.59
CA9 Q16790 3/20 0.59
NAAA Q02083 1/20 0.50
EPHX1 P07099 1/20 0.47
TSHR P16473 3/20 0.45
LPAR2 Q9HBW0 3/20 0.45
LPAR3 Q9UBY5 3/20 0.45
HCAR2 Q8TDS4 1/20 0.42
RAD52 P43351 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ALDH1A1 P00352 2/20 0.41
CYP2C9 P11712 1/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MEN1 O00255 1/20 0.41
THRB P10828 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31649164 1.00 CA12 (0.59) CA12CA1CA2CA9NAAA
SCHEMBL35171 1.00 CA12 (0.59) CA12CA1CA2CA9NAAA
SCHEMBL4742282 1.00 CA12 (0.59) CA12CA1CA2CA9NAAA
SCHEMBL31642602 1.00 CA12 (0.59) CA12CA1CA2CA9NAAA
SCHEMBL2190501 1.00 CA12 (0.59) CA12CA1CA2CA9NAAA
SCHEMBL2582137 1.00 CA12 (0.59) CA12CA1CA2CA9NAAA
SCHEMBL665183 1.00 CA12 (0.59) CA12CA1CA2CA9NAAA
SCHEMBL664650 1.00 CA12 (0.59) CA12CA1CA2CA9NAAA
SCHEMBL664655 1.00 CA12 (0.59) CA12CA1CA2CA9NAAA
SCHEMBL4742261 1.00 CA12 (0.59) CA12CA1CA2CA9NAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025129238-A1 A FLOTATION COLLECTOR COMPOSITION AND FLOTATION METHOD COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) 2025-06-26 WO disclosed
US-12227606-B2 Photocurable resin composition, photocurable resin article, and methods of fabricating the article THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-02-18 US disclosed
EP-3599077-B1 METHOD OF FORMING CONDUCTIVE THREE-DIMENSIONAL ARTICLES XEROX CORP (US) 2022-02-16 EP disclosed
US-20210238335-A1 Photocurable Resin Composition, Photocurable Resin Article, and Methods of Fabricating the Article THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION 2021-08-05 US disclosed
US-10982107-B2 Metal nanoparticle ink composition XEROX CORPORATION (US) 2021-04-20 US disclosed
US-10821658-B2 Conductive three-dimensional articles XEROX CORPORATION (US) 2020-11-03 US disclosed
WO-2020081891-A1 PHOTOCURABLE RESIN COMPOSITION, PHOTOCURABLE RESIN ARTICLE, AND METHODS OF FABRICATING THE ARTICLE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2020-04-23 WO disclosed
EP-3606297-A1 PRINTING PROCESS AND SYSTEM Xerox Corporation (US) 2020-02-05 EP disclosed
US-20200032088-A1 METAL NANOPARTICLE INK COMPOSITION XEROX CORPORATION (US) 2020-01-30 US disclosed
US-20200031041-A1 CONDUCTIVE THREE-DIMENSIONAL ARTICLES Genesee Valley Innovations, LLC 2020-01-30 US disclosed
EP-2114114-A1 Bimetallic nanoparticles for conductive ink applications Xerox Corporation (US) 2009-11-04 EP disclosed
CN-101559178-A Medicated thread for curing acute nephritis, chronic nephritis and chronic renal failure and application thereof SHOUDONG WANG (CN) 2009-10-21 CN disclosed
EP-2098316-A2 Metal nanoparticles stabilized with a bident amine Xerox Corporation (US) 2009-09-09 EP disclosed
US-20090214764-A1 METAL NANOPARTICLES STABILIZED WITH A BIDENT AMINE XEROX CORPORATION (US) 2009-08-27 US disclosed
EP-2080818-A2 Methods for removing a stabilizer from a metal nanoparticle using a destabilizer Xerox Corporation (US) 2009-07-22 EP disclosed
US-20090181177-A1 METHODS FOR REMOVING A STABILIZER FROM A METAL NANOPARTICLE USING A DESTABILIZER XEROX CORPORATION (US) 2009-07-16 US disclosed
US-20090148600-A1 Metal Nanoparticles Stabilized With a Carboxylic Acid-Organoamine Complex XEROX CORPORATION (US) 2009-06-11 US disclosed
US-20090140336-A1 SILVER NANOPARTICLE COMPOSITIONS XEROX CORPORATION (US) 2009-06-04 US disclosed
US-5707821-A Identification of phospholipase A2 inhibitors in Aβ peptide-mediated neurodegenerative disease ATHENA NEUROSCIENCES, INC. (US) 1998-01-13 US disclosed
US-5055211-A Lubricating oil containing a mixed ligand metal complex and a metal thiophosphate EXXON RESEARCH AND ENGINEERING COMPANY (US) 1991-10-08 US disclosed